Athenex athenex.com


Public list: Pharma Startups (4729) Cancer Therapeutics (1129)

Athenex (NASDAQ: ATNX), formerly Kinex Pharmaceuticals, is a global oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies. The company is dedicated to delivering innovative drugs that can have a life-changing impact on cancer patients. Its business includes medical technology innovation centers and a unique manufacturing supply chain across both China and North America. Through this connected inn...Show all

Athenex (NASDAQ: ATNX), formerly Kinex Pharmaceuticals, is a global oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies. The company is dedicated t...Show all

Company (IPO / Went public)

Phone: 716-898-8625

Fax:

1001 Main Street
Suite 600
Buffalo, 14203
New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Athenex $197M Jun 14, 2017
KAI Pharmaceuticals $63M Apr 11, 2012
CGI Pharmaceuticals $56.9M Jun 25, 2010
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Athenex Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors